IFN treatment, similarly to viral infection, activates RNase L, which cleaves single-stranded viral and host RNAs, leading to the activation of the RIG-I-like helicases RIG-I and MDA5 to amplify the production of IFN-β. Here, RIGI is linked to viral infectious disease.